Urgent

Airway pressure release ventilation (APRV)

APRV mode · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

APRV applies a sustained high continuous positive pressure (P-high) with brief timed releases (P-low) to a short expiratory time, allowing spontaneous breathing throughout. It is used as a rescue or open-lung strategy in selected hypoxaemic respiratory failure but lacks proven mortality benefit and carries risk if misapplied.

Red flags

  • Worsening hypoxaemia or hypercapnia after 2-4 h
  • Hypotension from high mean airway pressure
  • Pneumothorax / barotrauma
  • Patient apnoea leading to inadequate release ventilation
  • Rising CO2 with falling pH

Assessment

Differential diagnosis

  • Refractory ARDS
  • Atelectasis-prone lung
  • Post-operative hypoxaemia
  • Trauma lung contusion
  • Failure of conventional lung-protective ventilation

Investigations

  • ABG and P/F ratio
  • Continuous waveform and release-volume monitoring
  • Chest imaging
  • Haemodynamic assessment / echo for RV
  • End-expiratory flow analysis to set T-low

Management

  • Confirm patient has some spontaneous respiratory drive and is adequately but not deeply sedated
  • Set P-high near the prior plateau pressure, typically 25-30 cmH2O
  • Set T-high long, usually 4-6 s, to maximise mean airway pressure and recruitment
  • Set P-low to 0 cmH2O (auto-PEEP from short release maintains recruitment)
  • Set T-low short, 0.4-0.8 s, titrated so expiratory flow terminates at 50-75% of peak expiratory flow
  • Target total release ventilation to maintain acceptable CO2 clearance and pH above 7.20
  • Keep spontaneous breathing to augment dependent lung ventilation; avoid deep paralysis if possible
  • Monitor for haemodynamic compromise from high mean airway pressure and RV strain
  • Reassess oxygenation and compliance; if no improvement in 2-4 h consider reverting or proning
  • Wean by stepwise reduction of P-high and lengthening T-high (drop and stretch) toward CPAP
  • Avoid APRV in obstructive airways disease and significant air-trapping

Drugs & doses

Dexmedetomidine 0.2-1.4 mcg/kg/h IV (preserves respiratory drive)
Propofol 0.3-2 mg/kg/h IV infusion
Fentanyl 0.5-2 mcg/kg/h IV infusion

Disposition

ICU only, with senior intensivist directing mode selection and titration. Have a plan to revert to conventional ventilation if no benefit.

Complications & pitfalls

  • Barotrauma
  • RV failure from sustained high intrathoracic pressure
  • CO2 retention
  • Haemodynamic instability
  • Air trapping in obstructive disease

Exam pearls

  • T-low is set by expiratory flow, not time alone; terminate at 50-75% peak expiratory flow
  • APRV relies on spontaneous breathing - deep paralysis defeats its purpose
  • Not a proven mortality strategy; reserve for failure of standard lung-protective ventilation
  • Contraindicated in asthma/COPD due to air-trapping

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.